SCHEMBL7110877

SCHEMBL7110877

C=C(C)C(=O)NCC(C)OC(=O)C(OC(=O)CCC(=O)O)C(=O)OC(C)CNC(=O)C(=C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7110870 0.94 TSHR (0.32)
SCHEMBL5157071 0.90 KDM6B (0.33)
SCHEMBL7115526 0.83 TSHR (0.32)
SCHEMBL339839 0.79 TSHR (0.35)
SCHEMBL10016884 0.74 TSHR (0.32)
SCHEMBL16805864 0.74 TSHR (0.38)
SCHEMBL7110463 0.74 TDP1 (0.30)
SCHEMBL11419538 0.72 FAAH (0.36)
SCHEMBL20379691 0.72 TGFBR1 (0.42)
SCHEMBL24513273 0.70 TGFBR1 (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030078339-A1 Degradable cross-linking agents and cross-linked network polymers formed therewith ACCESS PHARMACEUTICALS, INC. 2003-04-24 US disclosed
US-6521431-B1 Cosmetic and drug-time release agents; hazardous waste remediation, metal chelation, wound healing agents ACCESS PHARMACEUTICALS, INC. 2003-02-18 US disclosed